Postprandial Mineral Metabolism and Secondary Hyperparathyroidism in Early CKD
Open Access
- 1 March 2008
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 19 (3) , 615-623
- https://doi.org/10.1681/asn.2007060673
Abstract
Normophosphatemia and normocalcemia are maintained in chronic kidney disease (CKD) by increased levels of fibroblast growth factor-23 (FGF-23) and parathyroid hormone (PTH), but the stimuli for secretion of these hormones in early CKD are incompletely understood. Most human physiologic studies have focused on random or fasting measurements of phosphorus, calcium, FGF-23, and PTH, but in this study, the hypothesis was that measurements in the postprandial state may reveal intermittent stimuli that lead to increased FGF-23 and PTH levels. The 4-h postprandial response in 13 patients with CKD and fasting normophosphatemia and normocalcemia (mean GFR 41 ± 8 ml/min per m2) was compared with 21 healthy volunteers. Compared with healthy subjects, fasting patients with CKD had significantly higher levels of FGF-23 and fractional excretion of phosphorus; lower fractional excretion of calcium; and no difference in serum calcium, phosphorus, and PTH levels. After standardized meals, urinary phosphorus excretion in both groups increased despite unchanged serum phosphorus and FGF-23 levels. Postprandial urinary calcium excretion also increased in both groups, and this was accompanied by significantly reduced serum calcium and increased PTH levels in patients with CKD only; therefore, FGF-23 does not seem to be an acute postprandial regulator of phosphaturia in CKD or in health, but inappropriate postprandial calciuria with episodic, relative hypocalcemia may represent a previously unreported mechanism of secondary hyperparathyroidism in CKD.Keywords
This publication has 44 references indexed in Scilit:
- Advances in Male ContraceptionEndocrine Reviews, 2008
- Vitamin D levels and early mortality among incident hemodialysis patientsKidney International, 2007
- Regulation of fibroblast growth factor-23 in chronic kidney diseaseNephrology Dialysis Transplantation, 2007
- Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy menKidney International, 2006
- Klotho converts canonical FGF receptor into a specific receptor for FGF23Nature, 2006
- Regulation of C-Terminal and Intact FGF-23 by Dietary Phosphate in Men and WomenJournal of Bone and Mineral Research, 2006
- Intestinal and Hepatic CYP3A4 Catalyze Hydroxylation of 1α,25-Dihydroxyvitamin D3: Implications for Drug-Induced OsteomalaciaMolecular Pharmacology, 2006
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationNew England Journal of Medicine, 2004
- Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteersKidney International, 2003
- Evidence for Secondary Hyperparathyroidism in Idiopathic HypercalciuriaJournal of Clinical Investigation, 1973